Phreesia faces securities fraud lawsuit
Analysis based on 8 articles · First reported May 22, 2026 · Last updated May 28, 2026
The market is impacted by the significant drop in Phreesia's stock price following its revised revenue projections, indicating investor concern over the company's financial outlook. The class action lawsuit against Phreesia could lead to further financial penalties and reputational damage for the company, affecting its market valuation.
A securities fraud class action lawsuit has been filed against Phreesia by the Law Offices of Howard G. Smith. The lawsuit alleges that Phreesia misled investors by creating a false impression of reliable long-term growth outlook and minimizing risks related to its Network Solutions segment. On March 30, 2026, Phreesia announced significantly lowered revenue growth projections for fiscal 2027, citing macroeconomic factors and weaker pharmaceutical marketing commitments. This news caused Phreesia's stock price to fall by 26.6% to $8.38 per share on March 31, 2026, injuring investors. Investors who purchased Phreesia common stock between May 8, 2025, and March 30, 2026, are encouraged to contact the Law Offices of Howard G. Smith to participate in the lawsuit, with a lead plaintiff motion deadline of July 13, 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard